Gastrointestinal Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
Semin Oncol. 2011 Aug;38(4):490-9. doi: 10.1053/j.seminoncol.2011.05.003.
Colon cancer is associated with a family history in up to 25% of cases. As many as 5% are associated with an established hereditary syndrome, demonstrating the profound influence of inheritable genetic mechanisms in the development of this disease. These syndromes confer a diverse spectrum of risk, age of presentation, endoscopic and histological findings, extracolonic manifestations, and modes of inheritance. As the molecular characteristics of these disorders become better described, enhanced genotype-phenotype correlations may offer a more targeted approach to diagnosis, screening, and surveillance. While the strategies for diagnosis and management of familial adenomatous polyposis (FAP) and Lynch syndrome are more established, the approach to newly recognized syndromes such as MUTYH-associated polyposis (MAP) and hyperplastic polyposis syndromes continues to evolve. Effective cancer prevention in affected individuals and at-risk family members first requires timely recognition of these hereditary colon cancer syndromes followed by integration of genetic testing and clinical examinations.
结直肠癌在多达 25%的病例中与家族史有关。多达 5%的病例与已确定的遗传性综合征有关,这表明可遗传的遗传机制在这种疾病的发展中具有深远的影响。这些综合征具有不同的风险、发病年龄、内镜和组织学发现、结肠外表现以及遗传方式。随着这些疾病的分子特征得到更好的描述,增强的基因型-表型相关性可能为诊断、筛查和监测提供更有针对性的方法。虽然家族性腺瘤性息肉病(FAP)和林奇综合征的诊断和管理策略已经更加成熟,但对新认识的综合征(如 MUTYH 相关息肉病(MAP)和增生性息肉综合征)的处理仍在不断发展。在受影响的个体和高危家庭成员中进行有效的癌症预防,首先需要及时识别这些遗传性结肠癌综合征,然后进行遗传测试和临床检查。